Skip to main content
. 2012 May 24;287(29):24195–24206. doi: 10.1074/jbc.M112.373936

FIGURE 2.

FIGURE 2.

Effects of KLF11 (TIEG2) on MAO A mRNA and catalytic activity in human neuroblastoma cells. A, levels of KLF11 protein (a), MAO A mRNA (b), and catalytic activity levels (c) were determined by Western blot analysis, quantitative real-time RT-PCR, and enzymatic activity assays, respectively, in KLF11-overexpressing SH-SY5Y cells with or without dexamethasone (Dex) treatment. Data are expressed as fold increase relative to the control. *, p < 0.02 or **, p < 0.05 compared with control in each group (for example, Ab, lane 2 versus lane 1 and lane 4 versus lane 3). Ac, p < 0.05 (shown at the top) compares between KLF11-overexpressed groups (lane 4 versus lane 2). B, levels of KLF11 protein (a), MAO A mRNA (b), and catalytic activity (c) levels were determined by Western blot analysis, quantitative real-time RT-PCR, and enzymatic activity assays, respectively, in KLF11-knockdown (siRNA) cells with or without Dex treatment. Data are expressed as fold changes relative to the control group. *, p < 0.02 or **, p < 0.05 compared with the control in each group (Bb, lane 4 versus lane 3).